230 related articles for article (PubMed ID: 16469521)
21. Transcriptome Analysis of Dermal Fibroblasts Derived From Visceral Leishmaniasis and Post-Kala-Azar Dermal Leishmaniasis Patients Reveal Disease-Specific Gene Expression and Pathological Regulation.
Singh S; Madhukar M; Dikhit MR; Ravidas VN; Pandey K; Sen A
J Infect Dis; 2023 May; 227(10):1132-1142. PubMed ID: 36821723
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
[TBL] [Abstract][Full Text] [Related]
23. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
Zijlstra EE
Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
[TBL] [Abstract][Full Text] [Related]
24. A comparison of five selective media for the primary isolation of Leishmania strains in India.
Ghosh AK; Ghosh DK; Bhattacharya A; Das P
Trop Med Parasitol; 1987 Sep; 38(3):187-90. PubMed ID: 3432954
[TBL] [Abstract][Full Text] [Related]
25. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
[TBL] [Abstract][Full Text] [Related]
26. Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.
Jaber HT; Hailu A; Pratlong F; Lami P; Bastien P; Jaffe CL
Infect Genet Evol; 2018 Nov; 65():80-90. PubMed ID: 30016714
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.
Khan MAA; Faisal K; Chowdhury R; Nath R; Ghosh P; Ghosh D; Hossain F; Abd El Wahed A; Mondal D
Parasit Vectors; 2021 Sep; 14(1):465. PubMed ID: 34503557
[TBL] [Abstract][Full Text] [Related]
28. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
29. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
Salotra P; Singh R
Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in post-kala-azar dermal leishmaniasis.
Mondal D; Khan MG
Curr Opin Infect Dis; 2011 Oct; 24(5):418-22. PubMed ID: 21885919
[TBL] [Abstract][Full Text] [Related]
31. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
[TBL] [Abstract][Full Text] [Related]
32. Post-kala-azar dermal leishmaniasis.
Zijlstra EE; Musa AM; Khalil EA; el-Hassan IM; el-Hassan AM
Lancet Infect Dis; 2003 Feb; 3(2):87-98. PubMed ID: 12560194
[TBL] [Abstract][Full Text] [Related]
33. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?
Addy M; Nandy A
Bull World Health Organ; 1992; 70(3):341-6. PubMed ID: 1638662
[TBL] [Abstract][Full Text] [Related]
34. Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis.
Singh AK; Das VNR; Amit A; Dikhit MR; Mahantesh V; Singh SK; Naryan S; Pandey K; Das P; Verma N; Bimal S
J Cell Biochem; 2018 Sep; 119(9):7406-7418. PubMed ID: 29775225
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
[TBL] [Abstract][Full Text] [Related]
36. Application of kDNA Minicircle PCR-RFLP to Characterize
Pokhrel O; Rai K; Bhattarai NR; Rijal S; Rijal A; Khanal B
Can J Infect Dis Med Microbiol; 2019; 2019():9392414. PubMed ID: 31467623
[TBL] [Abstract][Full Text] [Related]
37. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
[TBL] [Abstract][Full Text] [Related]
38. Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased
Cloots K; Marino P; Burza S; Gill N; Boelaert M; Hasker E
Front Cell Infect Microbiol; 2021; 11():604117. PubMed ID: 33777831
[TBL] [Abstract][Full Text] [Related]
39. Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?
El Hassan AM; Khalil EA
Trop Med Int Health; 2001 Sep; 6(9):743-4. PubMed ID: 11555443
[TBL] [Abstract][Full Text] [Related]
40. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
